<DOC>
	<DOCNO>NCT01644357</DOCNO>
	<brief_summary>Only well-designed study investigate effect pharmaceutical care asthma patient date publish study investigate effect specifically severe refractory asthma . The objective study evaluate effect pharmaceutical care asthma control quality life ( QoL ) patient severe refractory asthma compare pharmacist dispensation .</brief_summary>
	<brief_title>Effect 12-month Pharmaceutical Care Program Control Severe Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>Patients severe/refractory asthma present respiratory disease , ≥ 18 year age , use high dose inhale corticosteroid ( ≥ 800mcg budesonide equivalent ) FEV1 &lt; 60 % , regular visitor pharmacy physician . participation intervention study study , live city , could participate visit study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>